Unique versus shared neural correlates of externalizing psychopathology in late childhood
- PMID: 38869879
- PMCID: PMC11293992
- DOI: 10.1037/abn0000923
Unique versus shared neural correlates of externalizing psychopathology in late childhood
Abstract
Childhood externalizing psychopathology is heterogeneous. Symptom variability in conduct disorder (CD), oppositional defiant disorder (ODD), attention-deficit/hyperactivity disorder (ADHD), and callous-unemotional (CU) traits designate different subgroups of children with externalizing problems who have specific treatment needs. However, CD, ODD, ADHD, and CU traits are highly comorbid. Studies need to generate insights into shared versus unique risk mechanisms, including through the use of functional magnetic resonance imaging (fMRI). In this study, we tested whether symptoms of CD, ODD, ADHD, and CU traits were best represented within a bifactor framework, simultaneously modeling shared (i.e., general externalizing problems) and unique (i.e., symptom-specific) variance, or through a four-correlated factor or second-order factor model. Participants (N = 11,878, age, M = 9 years) were from the Adolescent Brain and Cognitive Development Study. We used questionnaire and functional magnetic resonance imaging data (emotional N-back task) from the baseline assessment. A bifactor model specifying a general externalizing and specific CD, ODD, ADHD, and CU traits factors demonstrated the best fit. The four-correlated and second-order factor models both fit the data well and were retained for analyses. Across models, reduced right amygdala activity to fearful faces was associated with more general externalizing problems and reduced dorsolateral prefrontal cortex activity to fearful faces was associated with higher CU traits. ADHD scores were related to greater right nucleus accumbens activation to fearful and happy faces. Results give insights into risk mechanisms underlying comorbidity and heterogeneity within externalizing psychopathology. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Figures



Similar articles
-
A Systematic Review and Meta-analysis of Neuroimaging in Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) Taking Attention-Deficit Hyperactivity Disorder (ADHD) Into Account.Neuropsychol Rev. 2016 Mar;26(1):44-72. doi: 10.1007/s11065-015-9315-8. Epub 2016 Feb 5. Neuropsychol Rev. 2016. PMID: 26846227 Free PMC article.
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2017 Aug 09;8:CD008559. doi: 10.1002/14651858.CD008559.pub3. PMID: 22972123 Updated.
-
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2023 Mar 27;3:CD009885. doi: 10.1002/14651858.CD009885.pub3. PMID: 26599576 Free PMC article. Updated.
-
The multispecifier model for conduct disorder in detained boys: Relations with conduct disorder criteria and etiologically and clinically relevant correlates.Personal Disord. 2025 Jan;16(1):31-42. doi: 10.1037/per0000708. Personal Disord. 2025. PMID: 39818929
Cited by
-
Heterogeneity of early-onset conduct problems: assessing different profiles, predictors and outcomes across childhood.Child Adolesc Psychiatry Ment Health. 2025 Apr 16;19(1):43. doi: 10.1186/s13034-025-00897-2. Child Adolesc Psychiatry Ment Health. 2025. PMID: 40241178 Free PMC article.
References
-
- Achenbach TM, & Rescorla LA (2001). The manual for the ASEBA school-age forms & profiles. University of Vermont, Research Center for Children, Youth, and Families.
-
- Aggensteiner P-M, Holz NE, Böttinger BW, Baumeister S, Hohmann S, Werhahn JE, Naaijen J, Ilbegi S, Glennon JC, Hoekstra PJ, Dietrich A, Deters RK, Saam MC, Schulze UME, Lythgoe DJ, Sethi A, Craig MC, Mastroianni M, Sagar-Ouriaghli I, … Brandeis D (2022). The effects of callous-unemotional traits and aggression subtypes on amygdala activity in response to negative faces. Psychological Medicine, 52(3), 476–484. 10.1017/S0033291720002111 - DOI - PubMed
-
- Balia C, Carucci S, Coghill D, & Zuddas A (2018). The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous—Unemotional traits modulate the efficacy of medication? Neuroscience & Biobehavioral Reviews, 91, 218–238. 10.1016/j.neubiorev.2017.01.024 - DOI - PubMed
MeSH terms
Grants and funding
- U24 DA041147/DA/NIDA NIH HHS/United States
- U01 DA051039/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- U01 DA051018/DA/NIDA NIH HHS/United States
- U01 DA041093/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA051038/DA/NIDA NIH HHS/United States
- U01 DA051037/DA/NIDA NIH HHS/United States
- U01 DA051016/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- U01 DA041174/DA/NIDA NIH HHS/United States
- U01 DA041134/DA/NIDA NIH HHS/United States
- U01 DA041022/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- U01 DA050987/DA/NIDA NIH HHS/United States
- U01 DA041025/DA/NIDA NIH HHS/United States
- U01 DA050989/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- U01 DA050988/DA/NIDA NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041048/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical